Ameritas Investment Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.64M Sell
19,539
-451
-2% -$93.7K 0.12% 135
2026
Q1
$4.22M Sell
19,990
-4,388
-18% -$945K 0.13% 131
2025
Q4
$5.01M Sell
24,378
-1,735
-7% -$327K 0.15% 107
2025
Q3
$4.1M Sell
26,113
-2,797
-10% -$432K 0.13% 140
2025
Q2
$4.86M Sell
28,910
-5,509
-16% -$818K 0.15% 100
2025
Q1
$4.74M Sell
34,419
-793
-2% -$101K 0.16% 90
2024
Q4
$4.16M Sell
35,212
-321
-0.9% -$37.5K 0.14% 120
2024
Q3
$3.93M Sell
35,533
-2,975
-8% -$311K 0.13% 138
2024
Q2
$3.79M Sell
38,508
-436
-1% -$44.4K 0.13% 132
2024
Q1
$4.36M Sell
38,944
-5,624
-13% -$607K 0.15% 110
2023
Q4
$4.49M Sell
44,568
-7,468
-14% -$741K 0.16% 92
2023
Q3
$4.52M Sell
52,036
-3,711
-7% -$335K 0.18% 83
2023
Q2
$5.27M Sell
55,747
-4,492
-7% -$379K 0.2% 74
2023
Q1
$4.55M Buy
60,239
+1,344
+2% +$101K 0.18% 90
2022
Q4
$4.52M Buy
58,895
+422
+0.7% +$32.1K 0.18% 90
2022
Q3
$3.9M Buy
58,473
+2,819
+5% +$179K 0.17% 100
2022
Q2
$2.91M Buy
55,654
+4,300
+8% +$244K 0.13% 141
2022
Q1
$2.91M Buy
51,354
+30,870
+151% +$1.65M 0.1% 190
2021
Q4
$1.05M Buy
20,484
+400
+2% +$19.6K 0.04% 617
2021
Q3
$992K Buy
20,084
+4,800
+31% +$260K 0.04% 613
2021
Q2
$871K Buy
15,284
+1,215
+9% +$71K 0.03% 664
2021
Q1
$783K Hold
14,069
0.03% 675
2020
Q4
$753K Buy
14,069
+940
+7% +$48.8K 0.03% 654
2020
Q3
$616K Buy
13,129
+1,400
+12% +$71.8K 0.03% 648
2020
Q2
$612K Sell
11,729
-393
-3% -$20.3K 0.03% 651
2020
Q1
$581K Hold
12,122
0.03% 575
2019
Q4
$613K Buy
12,122
+500
+4% +$25.8K 0.03% 697
2019
Q3
$548K Buy
11,622
+6,280
+118% +$287K 0.03% 712
2019
Q2
$252K Hold
5,342
0.01% 951
2019
Q1
$257K Hold
5,342
0.01% 921
2018
Q4
$238K Sell
5,342
-315
-6% -$16.4K 0.01% 895
2018
Q3
$305K Sell
5,657
-334
-6% -$17.1K 0.01% 870
2018
Q2
$293K Sell
5,991
-515
-8% -$29.2K 0.01% 876
2018
Q1
$408K Sell
6,506
-479
-7% -$32.9K 0.02% 801
2017
Q4
$428K Sell
6,985
-8,267
-54% -$511K 0.02% 791
2017
Q3
$1.02M Buy
15,252
+20
+0.1% +$1.41K 0.05% 513
2017
Q2
$1.19M Buy
15,232
+345
+2% +$26K 0.06% 449
2017
Q1
$1.21M Buy
14,887
+1,091
+8% +$85.9K 0.06% 427
2016
Q4
$992K Buy
13,796
+580
+4% +$41.9K 0.05% 511
2016
Q3
$1.03M Buy
13,216
+6,775
+105% +$548K 0.06% 466
2016
Q2
$502K Buy
6,441
+299
+5% +$23.8K 0.03% 595
2016
Q1
$503K Hold
6,142
0.03% 572
2015
Q4
$548K Hold
6,142
0.04% 503
2015
Q3
$472K Sell
6,142
-134
-2% -$11.2K 0.03% 562
2015
Q2
$525K Hold
6,276
0.03% 568
2015
Q1
$567K Hold
6,276
0.04% 544
2014
Q4
$507K Hold
6,276
0.03% 582
2014
Q3
$470K Sell
6,276
-500
-7% -$36.4K 0.03% 601
2014
Q2
$465K Hold
6,776
0.03% 630
2014
Q1
$474K Sell
6,776
-493
-7% -$34.3K 0.04% 590
2013
Q4
$486K Hold
7,269
0.04% 590
2013
Q3
$379K Buy
+7,269
New +$369K 0.04% 641

Other funds holding CAH

Ameritas Investment Partners's CAH Position: Q2 2026 in Review

Ameritas Investment Partners reduced its Cardinal Health (CAH) stake by 2.3% in Q2 2026, selling an estimated $93.7K and leaving 19,539 shares worth $4.64M. The position accounts for 0.12% of the portfolio, ranked #135.

Ameritas Investment Partners first reported a position in CAH in Q3 2013 and has held it in 52 quarters since. The position peaked at $5.27M in Q2 2023. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Ameritas Investment Partners held 19,539 shares of Cardinal Health worth $4.64M as of Q2 2026.
  • Ameritas Investment Partners sold 451 Cardinal Health shares in Q2 2026, an estimated $93.7K.
  • Cardinal Health made up 0.12% of Ameritas Investment Partners's portfolio in Q2 2026, its #135 holding.
  • Ameritas Investment Partners first reported a position in Cardinal Health in Q3 2013 and has held it in 52 quarters since.
  • Ameritas Investment Partners's Cardinal Health position peaked at $5.27M in Q2 2023.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.